NMPA Approval

Metformin Hydrochloride and Empagliflozin Tablets (Ⅰ)

Approval Number

国药准字H20249230

Company天大药业（珠海）有限公司

Registration Date

October 29, 2024

Drug Information

Generic Name

二甲双胍恩格列净片(Ⅰ)

Dosage Form

片剂

Strength

每片含盐酸二甲双胍500mg与恩格列净5mg

Drug Type

化学药品

Registration Date

October 29, 2024

Company Information

Applicant Company

Company Name天大药业（珠海）有限公司

Company Address

珠海市金湾区三灶镇定湾四路128号1栋第二层

Manufacturing Company

Company Name天大药业（珠海）有限公司

Company Address

珠海市金湾区三灶镇定湾四路128号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

二甲双胍恩格列净片(Ⅰ) - NMPA 批准文号 | MedPath